Picture of Noile-Immune Biotech logo

4893 — Noile-Immune Biotech News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareMicro CapSucker Stock

Table: Noile-Immune Biotech - 6-MTH parent results

    Aug 13 (Reuters)- 
             Noile-Immune Biotech Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Dec 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales                                 4 mln                     
                                     (+65.7 pct)                  
  Operating     loss 419 mln        loss 412 mln                  
  Recurring     loss 370 mln        loss 410 mln                  
  Net           loss 372 mln        loss 411 mln                  
  EPS           loss 8.59 yen       loss 9.51 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Noile-Immune Biotech Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T
    

Recent news on Noile-Immune Biotech

See all news